SEC Form D · Amendment · filed January 16, 2018
Cingulate Therapeutics
Rule 506(b): private placement to accredited investors, no public advertising.
People & firms on this filing (24)
Arthur B. Straughn · Cordova, TNDirectorShane J. Schaffer · Leawood, KSExec · DirectorMatthew N. Brams · Houston, TXExec · DirectorLaurie A. Myers · Lawrenceville, NJExec · DirectorCraig S. Gilgallon · Morristown, NJExecRaul R. Silva · Upper Grandview, NYExecPatrick J. Gallagher · Flanders, NJDirectorLouis G. Van Horn · Village of Loch Lloyd, MOExecThomas J. Marusak · Albany, NYDirectorMarious 5. Sjulsen · New York, NYExecAnton P. Feingold · New York, NYExec · DirectorJeff Kellam · Longview, TXDirectorJames A. Henderson · New York, NYExec · DirectorWilliam P. Phelan · Albany, NYExecDavid C. Michaels · Albany, NYExec · DirectorStelios R. Papadopoulos · San Diego, CAExecGeorge A. Overholser · KIRKLAND, WADirectorJohn H. Cox · Schaumburg, ILExecArrun Kapoor · Durham, NCExec · DirectorAlan Kelley · Durham, NCDirectorMark H. Sherman · Tiburon, CAExec · DirectorRonnie Wallace · Rome, GAExec · DirectorBryan Kelley · Rome, GAExecPaul R. Marcus · Boston, MAExec Public SEC Form D (Reg D) filing. · View issuer on SEC EDGAR ↗